BARCHIESI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 121
EU - Europa 66
AS - Asia 14
AF - Africa 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 208
Nazione #
US - Stati Uniti d'America 121
IT - Italia 54
DE - Germania 4
PH - Filippine 3
AU - Australia 2
JP - Giappone 2
SE - Svezia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
EG - Egitto 1
FI - Finlandia 1
FR - Francia 1
HK - Hong Kong 1
IN - India 1
IQ - Iraq 1
IR - Iran 1
LK - Sri Lanka 1
MY - Malesia 1
NL - Olanda 1
PL - Polonia 1
RO - Romania 1
SG - Singapore 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 208
Città #
Buffalo 13
Ashburn 8
Ancona 7
Chandler 7
Los Angeles 7
Marche 6
Chicago 5
Herndon 5
San Francisco 5
Boardman 4
Rome 4
Seattle 4
Council Bluffs 3
Lombard 3
Tavullia 3
Tolentino 3
Bologna 2
Dallas 2
Falconara Marittima 2
Ferrara 2
Henderson 2
Iesi 2
Melbourne 2
Milan 2
New York 2
Omaha 2
Portland 2
Reston 2
Aioicho 1
Albuquerque 1
Atlanta 1
Baghdad 1
Batangas 1
Berlin 1
Cabanatuan City 1
Cairo 1
Central 1
Chiaravalle 1
Columbus 1
Crugers 1
Dehiwala-Mount Lavinia 1
Deiva Marina 1
Des Moines 1
Dubai 1
Frankfurt am Main 1
Gainesville 1
Houston 1
Kampala 1
Kumamoto 1
Las Vegas 1
Lincoln 1
Mandaluyong City 1
Miami 1
Naples 1
New Orleans 1
Oulu 1
Padova 1
Paris 1
Pristina 1
Providence 1
Quiliano 1
Rotterdam 1
Sanaa 1
Santa Clara 1
Secaucus 1
Sungai Petani 1
Szczecin 1
The Bronx 1
Valperga 1
Zurich 1
Totale 153
Nome #
Candida guilliermondii fungemia in patients with hematologic malignancies., file e18b878f-db53-d302-e053-1705fe0a27c8 30
Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin., file e18b878f-db57-d302-e053-1705fe0a27c8 13
null, file 9bf311aa-7a5d-40c8-a051-7625edf01779 9
null, file e18b8791-e289-d302-e053-1705fe0a27c8 9
In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility., file e18b878f-daf8-d302-e053-1705fe0a27c8 8
Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot, file e18b878f-dad7-d302-e053-1705fe0a27c8 7
Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy, file e18b8791-2334-d302-e053-1705fe0a27c8 7
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study), file e18b8791-c309-d302-e053-1705fe0a27c8 7
Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2)., file e18b878f-c7d9-d302-e053-1705fe0a27c8 6
Comparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients., file e18b878f-dad3-d302-e053-1705fe0a27c8 6
Primary resistance to flucytosine among clinical isolates of Candida spp., file e18b878f-dadb-d302-e053-1705fe0a27c8 6
Effects of caspofungin against Candida guilliermondii and Candida parapsilosis., file e18b878f-f554-d302-e053-1705fe0a27c8 6
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole., file e18b878f-db4f-d302-e053-1705fe0a27c8 5
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp., file e18b8790-0843-d302-e053-1705fe0a27c8 5
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy, file e18b8791-4d0d-d302-e053-1705fe0a27c8 5
A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication, file e18b8791-b9eb-d302-e053-1705fe0a27c8 5
EUCAST technical note on Amphotericin B, file e18b878f-d820-d302-e053-1705fe0a27c8 4
Comparison of four methods for DNA typing of clinical isolates of Candida glabrata., file e18b878f-dad9-d302-e053-1705fe0a27c8 4
Antifungal susceptibility patterns of yeast isolates causing bloodstream infections., file e18b878f-dae3-d302-e053-1705fe0a27c8 4
Caspofungin in combination with amphotericin B against Candida parapsilosis., file e18b878f-db56-d302-e053-1705fe0a27c8 4
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole., file e18b8790-0287-d302-e053-1705fe0a27c8 4
Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU, file e18b8791-b9ea-d302-e053-1705fe0a27c8 4
Candidemia in intensive care units over nine years at a large Italian university hospital: Comparison with other wards, file e18b8791-c876-d302-e053-1705fe0a27c8 4
In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp., file e18b878f-dad8-d302-e053-1705fe0a27c8 3
Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting., file e18b878f-dadc-d302-e053-1705fe0a27c8 3
In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata., file e18b878f-dae7-d302-e053-1705fe0a27c8 3
Caspofungin in combination with amphotericin B against Candida glabrata., file e18b878f-db4d-d302-e053-1705fe0a27c8 3
Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata., file e18b878f-f5fd-d302-e053-1705fe0a27c8 3
In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens, file e18b8790-07f8-d302-e053-1705fe0a27c8 3
Efficacy of caspofungin against Aspergillus terreus, file e18b8790-0c8e-d302-e053-1705fe0a27c8 3
LA SIEROLOGIA TIPO-SPECIFICA PER HERPES SYMPLEX TIPO 2 NELLA GESTIONE DEI PAZIENTI HIV POSITIVI, file e18b8790-6dbb-d302-e053-1705fe0a27c8 3
Factors related to outcome of bloodstream infections due to Candida parapsilosis complex, file e18b8791-4d1f-d302-e053-1705fe0a27c8 3
Carbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients, file e18b8791-4f8d-d302-e053-1705fe0a27c8 3
Candidemia in the elderly: What does it change?, file e18b8791-4f8f-d302-e053-1705fe0a27c8 3
Antifungal combinations in dermatophytes, file e18b8791-dc3c-d302-e053-1705fe0a27c8 3
Epidemiology of onychomycosis and paronychia in the area of ANCONA (ITALY) over a period of 5 years, file e18b8790-0e69-d302-e053-1705fe0a27c8 2
ELECTROPHORETIC KARYOTYPING AND TRIAZOLE SUSCEPTIBILITY OF CANDIDA GLABRATA CLINICAL ISOLATES, file e18b8790-088f-d302-e053-1705fe0a27c8 1
An (Italian) proposal for a comprehensive approach to infections across the surgical pathway, file e18b8791-32d8-d302-e053-1705fe0a27c8 1
How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates, file e18b8791-334b-d302-e053-1705fe0a27c8 1
Prevalence and predictors of malignancies in HIV patients: results of a retrospective multicentric Italian cohort., file e18b8791-3ad8-d302-e053-1705fe0a27c8 1
Aspergillus spp invasive external otitis: favourable outcome with a medical approach, file e18b8791-3ec0-d302-e053-1705fe0a27c8 1
null, file e18b8791-4d14-d302-e053-1705fe0a27c8 1
Delay of antifungal therapy influences the outcome of invasive aspergillosis in experimental models of infection, file e18b8791-4d21-d302-e053-1705fe0a27c8 1
Characterisation of candidemia in patients with recent surgery: A 7-year experience, file e18b8791-90d7-d302-e053-1705fe0a27c8 1
Totale 208
Categoria #
all - tutte 20.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.292


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 0 0 0 0 7 4 0
2020/20212 0 0 0 0 0 0 2 0 0 0 0 0
2021/20221 0 0 0 0 0 0 0 0 0 0 0 1
2022/2023185 31 13 4 28 15 10 16 39 18 4 7 0
2023/20245 0 0 2 3 0 0 0 0 0 0 0 0
Totale 208